Wutah pendapatan taun lumaku: chromadex.com (CDXC)

The TTM revenue change demonstrates the environmental vector of ChromaDex Corporation (CDXC) through the implementation of ESG standards and packaging recycling. A global patent shield for the synthesis of Tru Niagen serves as a profit safeguard, restricting competitor access. The current 21.20 metric determines the parameter's status amid fierce competition for brand recognition in the unregulated longevity dietary supplement market.
ChromaDex (CDXC) - rincian metrik lan laporan keuangan

Effective international distribution of patented components under the stable management of ChromaDex Corporation (CDXC) correlates directly with the revenue dynamics shown on this 12-month YoY sales change chart. This indicator measures the daily growth rate of TTM annual turnover, adjusted for one-time write-offs, allowing investors to assess the real scalability of the business and confirm the sustainability of the asset's market value.